display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
breast cancer - triple negative
mBC - Triple negative (TNBC) - 1st Line (L1)
non platinum-based chemotherapy
taxanes
paclitaxel
nab-paclitaxel TORCHLIGHT TORCHLIGHT

Study type: